Moneta Group Investment Advisors LLC Charles River Laboratories International, Inc. Transaction History

Moneta Group Investment Advisors LLC

  • $9.24 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023
SELL
$194.44 - $217.61 $67,859 - $75,945
-349 Reduced 22.29%
1,217 $238,000
Q2 2023

Aug 15, 2023
BUY
$183.71 - $210.25 $44,825 - $51,301
244 Added 18.46%
1,566 $329,000
Q1 2023

May 15, 2023
BUY
$191.89 - $259.92 $253,678 - $343,614
1,322 New
1,322 $266,000
Q4 2022

Feb 16, 2023
SELL
$197.11 - $250.07 $270 Million - $343 Million
-1,370,253 Reduced 99.9%
1,372 $298,000
Q4 2022

Feb 15, 2023
BUY
$197.11 - $250.07 $270 Million - $343 Million
1,371,625 New
1,371,625 $299 Million

Others Institutions Holding CRL

# of Institutions
696
Shares Held
52.3M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Moneta Group Investment Advisors LLC Portfolio

Follow Moneta Group Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email